Nu-Med Plus (NUMD) Share-based Compensation Growth (5y) (2017 - 2022)
Powered by 
Analysis
Nu-Med Plus (NUMD) Share-based Compensation Growth (5y) (2017 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 7.00% |
| Dec 31, 2021 | -34.40% |
| Dec 31, 2020 | 20.38% |
| Sep 30, 2020 | -18.78% |
| Jun 30, 2020 | 22.93% |
| Mar 31, 2020 | -5.78% |
| Dec 31, 2019 | -4.23% |
| Sep 30, 2019 | -24.16% |
| Jun 30, 2019 | -20.03% |
| Mar 31, 2019 | -17.05% |
| Dec 31, 2018 | 35.02% |
| Sep 30, 2018 | 70.40% |
| Jun 30, 2018 | 149.32% |
| Dec 31, 2017 | -28.29% |
| Sep 30, 2017 | -1.52% |